Beta-endorphin, but not oxytocin, substance p or vasoactive-intestinal polypeptide, contributes to progesterone-induced prolactin secretion in monkeys

Neuroendocrinology

Volumn 63, Issue 6, 1996, Pages 569-578

  Pecins Thompson, Melanie ^a,b   Widmann, Andrea A ^a,b   Bethea, Cynthia L ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Beta endorphin; Gonadal steroids; Monkey; Naloxone; Oxytocin; Progesterone; Prolactin; Substance P; Vasoactive intestinal peptide

Indexed keywords

ATOSIBAN; BETA ENDORPHIN; ESTROGEN; NALOXONE; OPIATE ANTAGONIST; OXYTOCIN; PROLACTIN; SUBSTANCE P; SUBSTANCE P ANTAGONIST; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HYPOTHALAMUS; INTRAVENOUS DRUG ADMINISTRATION; MONKEY; NONHUMAN; PEPTIDERGIC NERVOUS SYSTEM; PREOPTIC AREA; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE;

ANIMALS; BETA-ENDORPHIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MACACA MULATTA; NALOXONE; OXYTOCIN; PROGESTERONE; PROLACTIN; SUBSTANCE P; TIME FACTORS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0029953928     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000127086     Document Type: Article

References (52)

1. Williams RF, Gianfortoni JG, Hodgen GD: Hyperprolactinemia induced by an estrogcn-progesteronc synergy: Quantitative and temporal effects of estrogen priming in monkeys, J Clin Endocrinol Metab 1985:60:126-132.
2. Sprangers SA, Brenner RM, Bethea CL: Estrogen and progestin receptor immunocytochem-istry in lactotropes versus gonadotropes of monkey pituitary cell cultures, Endocrinology 1989:124:1462-1470.
3. Sprangers SA, West NB, Brenner RM, Bethea CL: Regulation and localization of estrogen and progestin receptors in the pituitary of ste-roid-treated monkeys, Endocrinology 1990; 126:1133-1142.
4. Fox SR, Harlan RE, Shivers BD, Pfaft DW: Chemical characterization of neuroendocrine targets for progesterone in the female rat brain and pituitary- Neuroendocrinology 1990:51: 276-283.
5. Kohama SG, Frecsh F, Bethea CL: Immunocy-tochemical colocalization of hypothalamic progestin receptors and tyrosine hydroxylase in steroid-treated monkeys, Endocrinology 1992; 131:509-517.
6. Kohama SG, Bethea CL: Steroid regulation of tyrosine hydroxylase messenger ribonucleic acid in dopaminergic subpopulations of monkey hypothalamus, Endocrinology 1995; 136: 1790-1800.
7. Ben-Jonathan N, Arbogast LA, Hyde JF: Neuroendocrine regulation of prolactin release, Prog Neurobiol 1989;33:399-447.
8. Gold MS, Redmond DE, Donabedian RK: The effects of opiate agonist and antagonist on serum prolactin in primates: Possible role for endorphins in prolactin regulation, Endocrinology 1979;105:284-289.
9. Gordon K, Hodgen GD, Richardson DW: Postpartum lactational anovulation in a nonhuman primate (Macacafascicularis), Endogenous opiate mediation of suckling-induced hyperprolactinemia, J Clin Endocrinol Metab 1992:75:59-67.
10. Kehoe L, Parman R, Janik J, Callahan P: Opiate receptor subtype involvement in the stimulation of prolactin release by p-endorphin in female rats, Neuroendocrinology 1993:57: 875-883.
11. Sagrillo CA, Voogt JL: Mechanisms for the stimulatory effects of opioidergic and serotonergic input signals on prolactin in pregnant rats, Life Sci 1992:50:1479-1489.
12. Rivier C, Vale W, Ling N, Brown M, Guillcmin R: Stimulation in vivo of the secretion of prolactin and growth hormone by P-endorphin, Endocrinology 1977; 100:238-241.
13. Simantov R, Synder SH: Opiate receptor binding in the pituitary gland, Brain Res 1977; 124: 178-184.
14. Bethea CL, Widmann AA: Immunohistochcm-ical detection of progestin receptors in hypothalamic p-endorphin and substance P neurons of steroid treated monkeys, Neuroendocrinology 1996; in press.
15. Lumpkin MD, Samson WK, McCann SM: Hypothalamic and pituitary sites of action of oxytocin to alter prolactin secretion in the rat, Endocrinology 1983; 112:1711 -1717.
16. Chadio SE, Antoni FA: Specific oxytocin agonist stimulates prolactin release but has no effect on inositol phosphate accumulation in isolated rat anterior pituitary cells, J Mol Endocrinol 1993;10:107-114.
17. Arey BJ, Freeman ME: Oxytocin, vasoactive-intestinal peptide, and serotonin regulate the mating-induced surges of prolactin secretion in the rat, Endocrinology 1990;126:279-284.
18. Bethea CL, Kohama SG, Widmann AA: Search for progestin receptors (PR) in prolactin-releas-ing peptidergic neurons: Oxytocin neurons lack PR, but respond to gonadal steroids in monkeys, Endocrinology 1994; 134:945-953.
19. Vijavan E, McCann SM: In vivo and in vitro effects of substance P and neurotensin on gonadotropin and prolactin release, Endocrinology 1979;105:64-68.
20. Kato Y, Chihara K, Shozo O, Yoshiko I, Hi-romi A, Imura H: Growth hormone and prolactin release by substance P in rats, Life Sci 1976: 19:441-446
21. Ecksein N, Wehrenberg WB, Louis K, Carmel PW, Zinimermann EA, Ferin M: Effects of substance P on anterior pituitary secretion in the female rhesus monkey, Neuroendocrinology 1980:31:338-342.
22. Kato Y, Iwasaki Y, Iwasaki J, Abe H, Yanaiha-ra N, Imura H: Prolactin release by vasoactive intestinal polypeptide in rats, Endocrinology 1978;103:554-558.
23. Vijayan E, Samson WK, Said SI, McCann SM: Vasoactive intestinal peptide: Evidence for a hypothalamic site of action to release of growth hormone, luteinizing hormone, and prolactin in conscious ovariectomized rats, Endocrinology 1979:104:53-57.
24. Frawley LS, Neill JD: Stimulation of prolactin secretion in rhesus monkeys by vasoactive intestinal polypeptide, Neuroendocrinology 1981;33:79-83.
25. Enjalbert A, Arancibia S, Ruberg M, Priam M, Bluet-Pajol MT, Rotsztcjn WH, Kordon C: Stimulation of in vitro prolactin release by vasoactive intestinal peptide, Neuroendocrinology 1980:31:200-204.
26. Sliarr CJ, Clemens JA, Diningcr NB: Effect of vasoactive intestinal polypeptide on prolactin release in vitro, Life Sci 1979:25:2071-2074.
27. Bethea CL: Effect of vasoactive intestinal peptide on monkey prolactin secretion and cyclic AMP in culture: Interaction with estradiol and phenol red, Neuroendocrinologv 1990:51:576-585.
28. Picanco-Diniz DLW, Valenca MM, Franci CR, Antunes-Rodriges J: Role of substance P in the medial preoptic area in the regulation of gonadotropin and prolactin secretion in normal or orchidectomized rats, Neuroendocrinologv 1990:51:675-682.
29. Larsen PJ, Jessop D, Pate H, Lightman SL, Chowdrcy HS: Substance P inhibits the release of anterior pituitary adrenocorticotrophin via a central mechanism involving corticotrophin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus, J Neuroendocrinology 1993:5:99—105.
30. Gozcs I, Meltzer E, Rubinrout S, Brenneman DE, Fridkin M: Vasoactive intestinal peptide potentiates sexual behavior Inhibition by novel antagonist, Endocrinology 1989:125:2945— 2949.
31. Evans T, McCarthy KD, Harden TK: Regulation of cyclic AMP accumulation by peptide hormone receptors in immunocytochcmically defined astroglial cclls, J Neurochem 1984:41: 131-138.
32. Brenneman DE, Neale EA, Foster GA, d'Au-termont SW, Westbrook GL: Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide, J Cell Biol 1987:104:1603— 1610.
33. Bethea CL, PapkoffH: Purification of monkey prolactin from culture medium: Biochemical and immunological characterization, Proc Soc Exp Biol Med 1986:182:22-33.
34. Dave JR, Rubinstein N, Eskav RL: Evidence that P-endorphin binds to specific receptors in rat peripheral tissues and stimulates the adenylate cyclase-adenosine-3'.5'-monophosphatc system, Endocrinology 1985:1 17:1389-1396.
35. Eskay RL, Long RT, Iuvone PM: Evidence that TRH, somatostatin and substance P arc present in neurosecretory elements of the vertebrate retina, Brain Res 1980:196:554-559.
36. Eiden LE, Nilaver G, Palkovits M: Distribution of vasoactive intestinal polypeptide (VIP) in the rat brain stem nuclei, Brain Res 1982; 231:472-477.
37. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protcin-dvc binding, Anal Biochem 1976:72:248-254.
38. Gilbeau PM, Almircz RG, Holaday JW, Smith CG: Opioid effects on plasma concentrations of luteinizing hormone and prolactin in the adult male rhesus monkey, J Clin Endocrinol Metab 1989;60:299-305.
39. Wardlow SL, Wehrenberg WB, Ferin M, An-tunes JL, Frantz AG: Effect of sex steroids on P-endorphin or enkephalin in the hypothalamus of female guinea pigs, J Neurobiol 1990: 121:768-780.
40. Bethea CL, Hess DL, Widmann AA, Henning-feld JM: Effects of progesterone on prolactin, hypothalamic p-endorphin, hypothalamic substance P, and midbrain serotonin in guinea pigs, Neuroendocrinology 1995:61:695-703.
41. Wilkes MM, Yen SSC: Reduction by p-endor-phin of efflux of dopamine and dopac from superfused medial basal hypothalamus, Life Sci 1980;27:1387-1391.
42. Van Loon GR, De Souza EB, Shin SH: Dopaminergic mediation of p-endorphin-induced prolactin secretion, Neuroendocrinology 1980: 31:292-296.
43. Leadem CA, Crowley WR, Simpkins JW, Kal-ra SP: Effects of naloxone on catecholamine and LHRH release from the pcrifused hypothalamus of the steroid-primed rat, Neuroendocrinology 1985,40:497-500.
44. Arita J, Kimura F: Enkephalin inhibits dopa-minesynthcsis in vitro in the median eminence portion of rat hypothalamic slices, Endocrinology 1988;123:694-699.
45. Akesson TR, Miccvych PE: Estrogen concentration by substance P neurons in the medial basal hypothalamus of the female rat, J Neuro-sci Res 1988:19:412-419.
46. Nielsen KH, Blaustcin JD: Many progestin re-ceptor-containing neurons in the guinea pig ventrolateral hypothalamus contain substance P: Immunocytochcmical evidence, Brain Res 1990:517:175-181.
47. Gozcs I, Avidor R, Biejon A, Baldino F: Lactation elevated VIP messenger ribonucleic acid in rat suprachiasmatic nucleus, Endocrinology 1989:124:181-186.
48. Card JP, Brecha N, Kartcn JH, Moore RY: Immunocytochcmical localization of vasoactive intestinal polypeptide-containing cells and processes in the suprachiasmatic nucleus of the rat: Light and electron microscopic analysis, J Neurosci 1981:11:1289-1303.
49. Bethea CL, Fahrenbaeh WH, Sprangers SA, Freesh F: Immunocytochemical localization of progestin receptors in monkey hypothalamus: Effec; of estrogen and progestin, Endocrinology 1992;130:895-905.
50. Lam KSL: Vasoactive intestinal peptide in the hypothalamus and pituitary, Neuroendocrinology 1991;53(suppl 1):45—51.
51. Kaspsr S, Popescu RA, Torsello A, Vrontakis ME, Ikejiani C, Friesen HG: Tissue-specific regulation of vasoactive intestinal peptide messenger ribonucleic acid levels by estrogen in the rat, Endocrinology 1992;130:1796-1801.
52. Wanke IE, Rorstad OP: Receptors for vasoactive intestinal peptide in rat anterior pituitary glands: Localization of binding in lactotrophs, Endocrinology 1990:126:1981 -1988.